A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. This fireside chat was recorded during the Lytham Partners 2026 Investor...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is developing differentiated products designed to bridge critical gaps in current acute and chronic anticoagulation management for rare and high-risk patient populations. This fireside chat was recorded during the Lytham...
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into solid tumors. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
Viemed Healthcare, Inc., (Nasdaq: VMD) through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
LSL Pharma Group Inc. (TSXV: LSL) develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. This fireside chat was recorded during the Lytham Partners...
Beyond Air (Nasdaq: XAIR) is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders,...
Aurora Spine Corporation (OCTQB: ASAPF / TSXV: ASG) is focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. This fireside chat was recorded during the...
VitalHub (OTCQX: VHIBF / TSX: VHI) is a leading software company dedicated to empowering health and human services providers globally. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
INVO Fertility (Nasdaq: IVF) is a healthcare services fertility company dedicated to expanding assisted reproductive technology (“ART”) care to patients in need. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are...
Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
Biofrontera Inc. (Nasdaq: BFRI) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. This company webcast was...
Jaguar Health, Inc. (Nasdaq: JAGX) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically...
Reviva Pharma (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. This company...
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
NeurAxis, Inc., (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare...